COCRYSTAL PHARMA, INC. Lease, Cost
COCRYSTAL PHARMA, INC. (COCP) reported Lease, Cost of $163.00 thousand for the 1-month period ending 2024-08-31, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-13
- 2024-08-31: Lease, Cost 1 month $163.00K.
- 2024-08-01: Lease, Cost $163.00K.
- 2023-09-30: Lease, Cost 1 month $571.00K.
- 2023-09-01: Lease, Cost $571.00K.
| Period end | Lease, Cost | Lease, Cost 1 month |
|---|---|---|
| 2024-08-31 | $163.00K 10-Q · filed 2025-08-14 | |
| 2024-08-01 | $163.00K 10-Q · filed 2026-08-13 | |
| 2023-09-30 | $571.00K 10-Q · filed 2025-08-14 | |
| 2023-09-01 | $571.00K 10-Q · filed 2026-08-13 | |
| 2023-04-30 | $1.22M 10-Q · filed 2025-08-14 | |
| 2023-04-01 | $1.22M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |